Cancer, Cancer Treatment

NEW YORK (Reuters Health) - Data from the Women’s Health Initiative Observational Study show that higher than normal insulin levels are an independent risk factor for breast cancer.

Study investigators, led by Dr. Marc J. Gunter at Albert Einstein College of Medicine in the Bronx, New York, examined the association between breast cancer and blood parameters at study entry in 835 women who later developed breast cancer and 816 who did not. All of the women were postmenopausal and none were diabetic at baseline.

In the Journal of the National Cancer Institute, the researchers report a positive association between insulin levels and breast cancer risk, with women with the highest levels of insulin having a 46 percent greater risk than women with the lowest levels.

The association between insulin and breast cancer risk varied depending on whether or not the women took hormone therapy. Upon further analysis, insulin level was linked with breast cancer risk only in those who did not use hormones.

For women who did not use hormones, those with a body mass index of 30 (obese) compared with those with a BMI between 18 and 25 (normal weight), had a two-fold greater risk of breast cancer. Adjusting for insulin levels attenuated this association, however.

Fasting levels of estrogen were also linked with 59 percent higher risk among women with the highest versus the lowest estrogen levels.

Given that high levels of insulin and estrogen raise the risk for postmenopausal breast cancer — and largely account for the link between obesity and breast cancer — efforts to bring down fasting insulin or circulating estrogen levels “through weight loss or increased physical activity or via pharmacologic approaches” might be indicated, the researchers conclude.

SOURCE: Journal of the National Cancer Institute, January 2009.

Source

--------------------------------------------------------------------------------------------
Related Posts:

None Found

NEW YORK (Reuters Health) - Data from the Women’s Health Initiative Observational Study show that higher than normal insulin levels are an independent risk factor for breast cancer.

Study investigators, led by Dr. Marc J. Gunter at Albert Einstein College of Medicine in the Bronx, New York, examined the association between breast cancer and blood parameters at study entry in 835 women who later developed breast cancer and 816 who did not. All of the women were postmenopausal and none were diabetic at baseline.

In the Journal of the National Cancer Institute, the researchers report a positive association between insulin levels and breast cancer risk, with women with the highest levels of insulin having a 46 percent greater risk than women with the lowest levels.

The association between insulin and breast cancer risk varied depending on whether or not the women took hormone therapy. Upon further analysis, insulin level was linked with breast cancer risk only in those who did not use hormones.

For women who did not use hormones, those with a body mass index of 30 (obese) compared with those with a BMI between 18 and 25 (normal weight), had a two-fold greater risk of breast cancer. Adjusting for insulin levels attenuated this association, however.

Fasting levels of estrogen were also linked with 59 percent higher risk among women with the highest versus the lowest estrogen levels.

Given that high levels of insulin and estrogen raise the risk for postmenopausal breast cancer — and largely account for the link between obesity and breast cancer — efforts to bring down fasting insulin or circulating estrogen levels “through weight loss or increased physical activity or via pharmacologic approaches” might be indicated, the researchers conclude.

SOURCE: Journal of the National Cancer Institute, January 2009.

Source

--------------------------------------------------------------------------------------------
Related Posts:


WASHINGTON - Women who take hormone replacement therapy to treat menopause symptoms do not have a higher than usual risk of heart attack, especially if they use a cream or skin patch or take cyclic hormone combinations, Danish researchers reported yesterday. Their study, published in the European Heart Journal, suggests it is not hormone replacement therapy

Full Post: Study finds HRT does not increase heart attack risk
--------------------------------------------------------------------------------------------

Testosterone, the male sex hormone, boosts sexual desire and activities in postmenopausal women, according to a recent study. But a small review published earlier said the effect of the male hormone therapy on the risk of breast cancer remains uncertain. Off-label use of testosterone is allowed in the United States although the FDA has

Full Post: Testosterone patch drives women crazy in bedroom, but cancer risk uncertain
--------------------------------------------------------------------------------------------

Thursday October 16, 2008 (foodconsumer.org) — In the National Breast Cancer Awareness Month, you may do something to help yourselves reduce the risk of breast cancer. But first, equip yourselves with current knowledge about how to prevent the disease. We have published quite a few articles on breast cancer prevention because it is better

Full Post: Radiotherapy raises risk of contralateral breast cancer - Study
--------------------------------------------------------------------------------------------

FRIDAY, Oct. 17 — Mammograms detect 80 percent to 90 percent of breast cancers in women without symptoms, and all women 40 and older should get a yearly mammogram, says the American Cancer Society (ACS) as it marks National Mammography Day on Friday, Oct. 17. “Mammography remains the most effective screening test for the early detection

Full Post: Mammograms Remain Best Way to Spot Breast Cancer
--------------------------------------------------------------------------------------------

MONDAY, Nov. 17 — Psychological counseling may improve the chances of survival for breast cancer patients, a new study says. Sessions that concentrate on mood improvement, effective coping and altering health behaviors appear to reduce stress and help the patient live longer, according to the report, published in the Dec. 15 issue of Cancer. “If efficacious psychological

Full Post: Psychological Counseling Boosts Breast Cancer Outcomes